Literature DB >> 32886196

Validation of the German Classification of Diverticular Disease (VADIS)-a prospective bicentric observational study.

Johannes C Lauscher1, Johan F Lock2, Katja Aschenbrenner3, Rahel M Strobel3, Marja Leonhardt4, Andrea Stroux5,6, Benjamin Weixler3, Christoph-Thomas Germer2, Martin E Kreis3.   

Abstract

PURPOSE: The German Classification of Diverticular Disease was introduced a few years ago. The aim of this study was to determine whether Classification of Diverticular Disease enables an exact stratification of different types of diverticular disease in terms of course and treatment.
METHODS: This was a prospective, bicentric observational trial. Patients aged ≥ 18 years with diverticular disease were prospectively included. The primary endpoint was the rate of recurrence within 2 year follow-up. Secondary outcome measures were Gastrointestinal Quality of Life Index, Quality of life measured by SF-36, frequency of gastrointestinal complaints, and postoperative complications.
RESULTS: A total of 172 patients were included. After conservative management, 40% of patients required surgery for recurrence in type 1b vs. 80% in type 2a/b (p = 0.04). Sixty percent of patients with type 2a (micro-abscess) were in need of surgery for recurrence vs. 100% of patients with type 2b (macro-abscess) (p = 0.11). Patients with type 2a reached 123 ± 15 points in the Gastrointestinal Quality of Life Index compared with 111 ± 14 in type 2b (p = 0.05) and higher scores in the "Mental Component Summary" scale of SF-36 (52 ± 10 vs. 43 ± 13; p = 0.04). Patients with recurrent diverticulitis without complications (type 3b) had less often painful constipation (30% vs. 73%; p = 0.006) when they were operated compared with conservative treatment.
CONCLUSION: Differentiation into type 2a and 2b based on abscess size seems reasonable as patients with type 2b required surgery while patients with type 2a may be treated conservatively. Sigmoid colectomy in patients with type 3b seems to have gastrointestinal complaints during long-term follow-up. TRIAL REGISTRATION: https://www.drks.de ID: DRKS00005576.

Entities:  

Keywords:  Classification; Conservative treatment; Diverticular disease; Prospective trial; Quality of life; Recurrence; Surgical treatment

Mesh:

Year:  2020        PMID: 32886196      PMCID: PMC7782437          DOI: 10.1007/s00384-020-03721-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  19 in total

1.  Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial.

Authors:  Bryan J M van de Wall; Marguerite A W Stam; Werner A Draaisma; R Stellato; Willem A Bemelman; Marja A Boermeester; Ivo A M J Broeders; Eric J Belgers; Boudewijn R Toorenvliet; Hubert A Prins; Esther C J Consten
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-19

2.  [S2k guidelines diverticular disease/diverticulitis].

Authors:  L Leifeld; C T Germer; S Böhm; F L Dumoulin; W Häuser; M Kreis; J Labenz; B Lembcke; S Post; M Reinshagen; J-P Ritz; T Sauerbruch; T Wedel; B von Rahden; W Kruis
Journal:  Z Gastroenterol       Date:  2014-07-15       Impact factor: 2.000

3.  Microscopic findings in sigmoid diverticulitis--changes after conservative therapy.

Authors:  Christoph Holmer; Kai S Lehmann; Sabrina Engelmann; Bernd Frericks; Christoph Loddenkemper; Heinz J Buhr; Jörg-Peter Ritz
Journal:  J Gastrointest Surg       Date:  2010-02-25       Impact factor: 3.452

4.  Indications for elective sigmoid resection in diverticular disease.

Authors:  Bastiaan R Klarenbeek; Michelle Samuels; Maarten A van der Wal; Donald L van der Peet; Wilhelmus J Meijerink; Miguel A Cuesta
Journal:  Ann Surg       Date:  2010-04       Impact factor: 12.969

5.  Prospective, five-year follow-up study of patients with symptomatic uncomplicated diverticular disease.

Authors:  Tarek A Salem; Richard G Molloy; Patrick J O'Dwyer
Journal:  Dis Colon Rectum       Date:  2007-09       Impact factor: 4.585

6.  S2k Guidlines for Diverticular Disease and Diverticulitis: Diagnosis, Classification, and Therapy for the Radiologist.

Authors:  A G Schreyer; G Layer
Journal:  Rofo       Date:  2015-05-27

7.  Long-term quality of life after conservative treatment versus surgery for different stages of acute sigmoid diverticulitis.

Authors:  Martina Brandlhuber; Christian Genzinger; Bernhard Brandlhuber; Wieland H Sommer; Mario H Müller; Martin E Kreis
Journal:  Int J Colorectal Dis       Date:  2018-02-03       Impact factor: 2.571

8.  Treatment of perforated diverticular disease of the colon.

Authors:  E J Hinchey; P G Schaal; G K Richards
Journal:  Adv Surg       Date:  1978

9.  Gastrointestinal Quality of Life Index: development, validation and application of a new instrument.

Authors:  E Eypasch; J I Williams; S Wood-Dauphinee; B M Ure; C Schmülling; E Neugebauer; H Troidl
Journal:  Br J Surg       Date:  1995-02       Impact factor: 6.939

Review 10.  Review of current classifications for diverticular disease and a translation into clinical practice.

Authors:  Bastiaan R Klarenbeek; Niels de Korte; Donald L van der Peet; Miguel A Cuesta
Journal:  Int J Colorectal Dis       Date:  2011-09-17       Impact factor: 2.571

View more
  3 in total

1.  Value of high-field magnetic resonance imaging for diagnosis and classification of acute colonic diverticulitis.

Authors:  Markus Lurz; Angelos Gazis; Stefanie Hanschke; Arved Weimann; Arnd-Oliver Schäfer
Journal:  Int J Colorectal Dis       Date:  2021-10-11       Impact factor: 2.571

Review 2.  [Indications for surgical treatment of diverticular disease].

Authors:  Johan Lock; A Wiegering; C-T Germer
Journal:  Chirurg       Date:  2021-06-07       Impact factor: 0.955

3.  Early elective versus elective sigmoid resection in diverticular disease: not only timing matters-a single institutional retrospective review of 133 patients.

Authors:  Sascha Vaghiri; David Mario Jagalla; Dimitrios Prassas; Wolfram Trudo Knoefel; Andreas Krieg
Journal:  Langenbecks Arch Surg       Date:  2022-02-22       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.